Danielle Anderson, FNP-C
NPI 1629778014 · Family Nurse Practitioner · Maple Grove, MN
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1629778014
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- FNP-C
- Sex
- Female
- Sole proprietor
- No
- License
- 9994 (MN)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
3 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
342 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 126 | $74 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 97 | $105 |
| Testing for Presence of Drug, By Chemistry Analyzers80307 | 62 | $61 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0482 | 43 | $195 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0480 | 14 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 161 | 76 |
| Oxycodone Hcl | 148 | 45 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 129 | 57 |
| Gabapentin | 112 | 31 |
| Morphine Sulfatebrand: Morphine Sulfate Er | 91 | 24 |
| Tizanidine Hcl | 77 | 34 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,275 across 21 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2023-03-06
- Last updated
- 2023-04-07
- Certified
- 2023-04-07
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.